Company / Operating Income per Share
Edesa Biotech, Inc. Operating Income per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.67
FY2021
5-year range
-$3.48 / -$0.38
FY2017-FY2021
Trend
-76.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 5 years, ranging from $-3.48 in FY2018 to $-0.38 in FY2020.
Based on SEC 10-K filings.
-0.67 in FY2021.
Improved from $-3.48 to $-0.67 over the past 3 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating income per share decreased 76.4% year-over-year.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$0.67 | -76.4% |
| FY2020 | -$0.38 | +89.1% |
| FY2018 | -$3.48 | -712.2% |
| FY2017 | -$0.43 | +40.2% |
| FY2016 | -$0.72 | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026